ES2076248T3 - Dibenzofuranos substituidos y metodos para el uso de los mismos. - Google Patents

Dibenzofuranos substituidos y metodos para el uso de los mismos.

Info

Publication number
ES2076248T3
ES2076248T3 ES90108031T ES90108031T ES2076248T3 ES 2076248 T3 ES2076248 T3 ES 2076248T3 ES 90108031 T ES90108031 T ES 90108031T ES 90108031 T ES90108031 T ES 90108031T ES 2076248 T3 ES2076248 T3 ES 2076248T3
Authority
ES
Spain
Prior art keywords
dibenzofuranes
substituted
methods
components
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90108031T
Other languages
English (en)
Inventor
Scott T Shoupe
Stephen M Coutts
David C Baker
Elli S Hand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Application granted granted Critical
Publication of ES2076248T3 publication Critical patent/ES2076248T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SON DESCUBIERTOS NUEVOS COMPONENTES DIBENZOFURANOS SUSTITUIDOS. LOS COMPONENTES MUESTRAN ACTIVIDAD EN ANTAGONIZAR LOS EFECTOS DEL LEUKOTRIENO B4 (LTB4). SON TAMBIEN DESCRITAS LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS NUEVOS COMPONENTES Y LOS METODOS DE TRATAMIENTO QUE EMPLEAN EL MISMO.
ES90108031T 1989-09-19 1990-04-27 Dibenzofuranos substituidos y metodos para el uso de los mismos. Expired - Lifetime ES2076248T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/409,630 US5019573A (en) 1989-09-19 1989-09-19 Substituted dibenzofurans and methods of using same

Publications (1)

Publication Number Publication Date
ES2076248T3 true ES2076248T3 (es) 1995-11-01

Family

ID=23621327

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90108031T Expired - Lifetime ES2076248T3 (es) 1989-09-19 1990-04-27 Dibenzofuranos substituidos y metodos para el uso de los mismos.

Country Status (22)

Country Link
US (1) US5019573A (es)
EP (1) EP0422329B1 (es)
JP (1) JPH03145484A (es)
KR (1) KR0155556B1 (es)
CN (1) CN1042030C (es)
AR (1) AR248405A1 (es)
AT (1) ATE125534T1 (es)
AU (1) AU632851B2 (es)
CA (1) CA2013960C (es)
DE (1) DE69021162T2 (es)
DK (1) DK0422329T3 (es)
EG (1) EG19729A (es)
ES (1) ES2076248T3 (es)
FI (1) FI904448A7 (es)
GR (1) GR3017784T3 (es)
IE (1) IE69050B1 (es)
IL (1) IL93856A (es)
NO (1) NO175780C (es)
NZ (1) NZ233058A (es)
PH (1) PH26748A (es)
PT (1) PT95362B (es)
ZA (1) ZA902345B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980369A (en) * 1989-09-19 1990-12-25 Allergan, Inc. Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl or thiochromanyl group having retinoid-like activity
US7850970B2 (en) 2003-08-26 2010-12-14 The Regents Of The University Of Colorado Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
US8158362B2 (en) 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
CN1318411C (zh) * 2005-03-21 2007-05-30 中国海洋大学 氢化轮枝霉酮类化合物及其制备方法和用途
US20080124303A1 (en) * 2005-12-12 2008-05-29 Cavit Sciences, Inc Methods and compositions for treatment of viral infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867409A (en) * 1969-06-16 1975-02-18 Richardson Merrell Inc Bis-basic esters of dibenzofuran
US3649651A (en) * 1969-07-02 1972-03-14 American Home Prod Dibenzofuran derivatives and preparation thereof
US4022805A (en) * 1974-03-07 1977-05-10 Hoffmann-La Roche Inc. 8-Halo-dibenzofuran-3-acetic acids and certain esters thereof
US4769387A (en) * 1987-11-13 1988-09-06 Abbott Laboratories Dibenzofuran lipoxygenase inhibiting compounds, compositions and use

Also Published As

Publication number Publication date
KR910006262A (ko) 1991-04-29
PH26748A (en) 1992-09-28
EP0422329A1 (en) 1991-04-17
IE902836A1 (en) 1991-03-27
ATE125534T1 (de) 1995-08-15
IE69050B1 (en) 1996-08-07
EP0422329B1 (en) 1995-07-26
IL93856A (en) 1996-08-04
US5019573A (en) 1991-05-28
DK0422329T3 (da) 1995-09-11
AU632851B2 (en) 1993-01-14
CA2013960C (en) 2000-06-27
ZA902345B (en) 1990-12-28
NO175780C (no) 1994-12-07
AU6265190A (en) 1991-03-28
AR248405A1 (es) 1995-08-18
GR3017784T3 (en) 1996-01-31
DE69021162T2 (de) 1996-02-15
CA2013960A1 (en) 1991-03-19
PT95362A (pt) 1991-06-25
CN1050384A (zh) 1991-04-03
JPH03145484A (ja) 1991-06-20
EG19729A (en) 1996-01-31
IL93856A0 (en) 1990-12-23
KR0155556B1 (ko) 1998-11-16
FI904448A0 (fi) 1990-09-10
FI904448A7 (fi) 1991-03-20
NZ233058A (en) 1991-05-28
PT95362B (pt) 1997-06-30
NO904060L (no) 1991-03-20
NO904060D0 (no) 1990-09-18
DE69021162D1 (de) 1995-08-31
NO175780B (no) 1994-08-29
CN1042030C (zh) 1999-02-10

Similar Documents

Publication Publication Date Title
ES2056214T3 (es) Compuestos de benzopirido-piperidina, -piperidilideno y -piperazina, composiciones, metodos de preparacion y metodos de uso.
ES2059207T3 (es) Procedimiento para la preparacion de derivados del taxano, nuevos derivados obtenidos y composiciones farmaceuticas que les contienen.
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
MX9704777A (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y composiciones que los contienen.
ES2071486T3 (es) Derivado de la 5h-pirrolo(3,4-b)pirazina opticamente activa, su preparacion y las composiciones farmaceuticas que le contienen.
ES2161697T3 (es) Peptidos agonistas de amilina y usos de los mismos.
AR003455A1 (es) Derivados tetraciclicos, su uso en la preparacion de un medicamento, un metodo de tratamiento, una composicion farmaceutica y procesos para lapreparacion de una composicion farmaceutica y para preparar los compuestos.
ATE26115T1 (de) Substituierte 8-phenylxanthine.
ES2040261T3 (es) Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos.
ES2186783T3 (es) Derivados de la dolastatina, su preparacion y uso.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES507807A0 (es) Procedimiento para la obtencion de derivados triciclicos de citosina.
ES2059534T3 (es) Nuevos derivados benzopiranos antihipertensivos.
IT8920929A0 (it) Nuovi derivati del r( ) 3 chinuclidinolo.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2076248T3 (es) Dibenzofuranos substituidos y metodos para el uso de los mismos.
MX9401172A (es) Derivados fluorados de 4-aminoandrostadienona, procesamiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2053535T3 (es) Derivados heterociclicos de cinco miembros de n,n'-diacilhidrazinas n' sustituidas.
ES2054790T3 (es) Compuestos que tienen actividad cardiovascular.
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
IT8222911A0 (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 422329

Country of ref document: ES